Published in Proc Natl Acad Sci U S A on May 14, 2002
Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells. Genome Res (2010) 2.64
A global role for EKLF in definitive and primitive erythropoiesis. Blood (2005) 2.24
The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability. Mol Cell Biol (2005) 2.11
The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood (2011) 1.93
Characterization of glycolytic enzyme interactions with murine erythrocyte membranes in wild-type and membrane protein knockout mice. Blood (2008) 1.23
Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1. J Biol Chem (2008) 1.18
The effector domain of human Dlg tumor suppressor acts as a switch that relieves autoinhibition of kinesin-3 motor GAKIN/KIF13B. Biochemistry (2007) 1.10
Regulatory models of RhoA suppression by dematin, a cytoskeletal adaptor protein. Cell Adh Migr (2009) 0.94
Refined views of multi-protein complexes in the erythrocyte membrane. Blood Cells Mol Dis (2012) 0.90
Identification of a novel role for dematin in regulating red cell membrane function by modulating spectrin-actin interaction. J Biol Chem (2012) 0.90
Transcriptional mechanisms underlying hemoglobin synthesis. Cold Spring Harb Perspect Med (2013) 0.90
Role for parasite genetic diversity in differential host responses to Trypanosoma brucei infection. Infect Immun (2010) 0.88
UCP2 modulates cell proliferation through the MAPK/ERK pathway during erythropoiesis and has no effect on heme biosynthesis. J Biol Chem (2008) 0.87
Proteomic analysis shows the upregulation of erythrocyte dematin in zinc-restricted human subjects. Am J Clin Nutr (2012) 0.84
Dematin, a component of the erythrocyte membrane skeleton, is internalized by the malaria parasite and associates with Plasmodium 14-3-3. J Biol Chem (2010) 0.83
Dematin exhibits a natively unfolded core domain and an independently folded headpiece domain. Protein Sci (2009) 0.83
The headpiece domain of dematin regulates cell shape, motility, and wound healing by modulating RhoA activation. Mol Cell Biol (2008) 0.82
Gene disruption of dematin causes precipitous loss of erythrocyte membrane stability and severe hemolytic anemia. Blood (2016) 0.79
Phosphorylation-induced changes in backbone dynamics of the dematin headpiece C-terminal domain. J Biomol NMR (2008) 0.78
The allosteric mechanism induced by protein kinase A (PKA) phosphorylation of dematin (band 4.9). J Biol Chem (2013) 0.78
Single-cell electrical lysis of erythrocytes detects deficiencies in the cytoskeletal protein network. Lab Chip (2011) 0.78
Headpiece domain of dematin regulates calcium mobilization and signaling in platelets. J Biol Chem (2012) 0.77
Atomic force microscopy demonstration of cytoskeleton instability in mouse erythrocytes with dematin-headpiece and β-adducin deficiency. Scanning (2011) 0.77
Effects of radiographic contrast media on the micromorphology of the junctional complex of erythrocytes visualized by immunocytology. Int J Mol Sci (2014) 0.76
Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation. Clin Proteomics (2013) 0.76
Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry (1971) 66.90
The organization of proteins in the human red blood cell membrane. A review. J Cell Biol (1974) 9.84
Cytoskeleton--plasma membrane interactions. Science (1992) 4.44
Visualization of the protein associations in the erythrocyte membrane skeleton. Proc Natl Acad Sci U S A (1985) 3.26
The spectrin-based membrane skeleton and micron-scale organization of the plasma membrane. Annu Rev Cell Biol (1993) 2.62
The spectrin-actin junction of erythrocyte membrane skeletons. Biochim Biophys Acta (1989) 2.50
The molecular basis of erythrocyte shape. Science (1986) 2.20
Ultrastructure of the intact skeleton of the human erythrocyte membrane. J Cell Biol (1986) 2.07
Integral membrane protein interaction with Triton cytoskeletons of erythrocytes. Biochim Biophys Acta (1979) 2.00
Modulation of spectrin-actin assembly by erythrocyte adducin. Nature (1987) 1.89
Erythrocyte adducin: a calmodulin-regulated actin-bundling protein that stimulates spectrin-actin binding. J Cell Biol (1987) 1.83
In vivo, villin is required for Ca(2+)-dependent F-actin disruption in intestinal brush borders. J Cell Biol (1999) 1.69
Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance. Blood (1983) 1.64
A new function for adducin. Calcium/calmodulin-regulated capping of the barbed ends of actin filaments. J Biol Chem (1996) 1.63
Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice. Proc Natl Acad Sci U S A (1999) 1.57
Partial purification and characterization of an actin-bundling protein, band 4.9, from human erythrocytes. J Cell Biol (1985) 1.52
Targeted disruption of the mouse villin gene does not impair the morphogenesis of microvilli. Dev Dyn (1998) 1.51
Altered spectrin dimer-dimer association and instability of erythrocyte membrane skeletons in hereditary pyropoikilocytosis. J Clin Invest (1981) 1.49
A technique to detect reduced mechanical stability of red cell membranes: relevance to elliptocytic disorders. Blood (1982) 1.49
Primary structure and domain organization of human alpha and beta adducin. J Cell Biol (1991) 1.27
Spontaneous, reversible protein cross-linking in the human erythrocyte membrane. Temperature and pH dependence. Biochemistry (1977) 1.23
Abolition of actin-bundling by phosphorylation of human erythrocyte protein 4.9. Nature (1988) 1.17
Cloning of human erythroid dematin reveals another member of the villin family. Proc Natl Acad Sci U S A (1993) 1.17
Purification of erythrocyte dematin (protein 4.9) reveals an endogenous protein kinase that modulates actin-bundling activity. J Biol Chem (1989) 1.12
The junctional complex of the membrane skeleton. Semin Hematol (1993) 1.11
Mild spherocytic hereditary elliptocytosis and altered levels of alpha- and gamma-adducins in beta-adducin-deficient mice. Blood (2000) 1.09
Isoform cloning, actin binding, and chromosomal localization of human erythroid dematin, a member of the villin superfamily. J Biol Chem (1995) 1.09
Protein immunolocalization in the spread erythrocyte membrane skeleton. Eur J Cell Biol (1992) 1.07
Villin function in the organization of the actin cytoskeleton. Correlation of in vivo effects to its biochemical activities in vitro. J Biol Chem (1999) 1.04
Protein kinase C of human erythrocytes phosphorylates bands 4.1 and 4.9. Biochim Biophys Acta (1986) 0.91
Ektacytometry of red blood cells. Methods Enzymol (1989) 0.90
Human erythrocyte dematin and protein 4.2 (pallidin) are ATP binding proteins. Biochemistry (1996) 0.87
Further investigations of red cell deformability with nickel mesh. Biorheology (1990) 0.83
cDNA sequence, genomic structure, and expression of the mouse dematin gene (Epb4.9). Mamm Genome (1999) 0.83
Alternative splicing and structure of the human erythroid dematin gene. Biochim Biophys Acta (1998) 0.80
The solubilization of cytoskeletons of human erythrocyte membranes by p-mercuribenzene sulphonate. Biochim Biophys Acta (1983) 0.80
Cross-linkings between spectrin and band 3 in human erythroycte membranes. J Supramol Struct (1979) 0.78
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell (2005) 7.99
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med (2011) 7.82
Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet (2009) 6.35
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem (2005) 4.65
In vitro and in vivo two-photon luminescence imaging of single gold nanorods. Proc Natl Acad Sci U S A (2005) 3.66
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature (2010) 3.39
Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg (2011) 2.86
In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc Natl Acad Sci U S A (2007) 2.70
Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev (2002) 2.56
Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci (2005) 2.46
Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc Natl Acad Sci U S A (2005) 2.44
Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J Clin Invest (2007) 2.39
Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood (2013) 2.27
Quantitative and qualitative 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in skull base meningiomas. Neurosurg Focus (2011) 2.22
Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy. Am J Physiol Cell Physiol (2004) 2.16
Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood (2006) 2.16
Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol Oncol (2008) 2.01
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med (2012) 1.99
Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging. Langmuir (2008) 1.88
Mechanisms and implications of imatinib resistance mutations in BCR-ABL. Curr Opin Hematol (2004) 1.83
Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4. J Biol Chem (2004) 1.81
Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes. Proc Natl Acad Sci U S A (2003) 1.79
Folate-targeted therapies for cancer. J Med Chem (2010) 1.73
Folate receptor overexpression is associated with poor outcome in breast cancer. Int J Cancer (2007) 1.65
Oxygen gas-filled microparticles provide intravenous oxygen delivery. Sci Transl Med (2012) 1.65
Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging. Proc Natl Acad Sci U S A (2006) 1.65
Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunol Immunother (2002) 1.63
Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. Adv Drug Deliv Rev (2004) 1.59
Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev (2004) 1.58
Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev (2008) 1.58
5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells. Br J Haematol (2005) 1.58
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chim Acta (2012) 1.51
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Transfusion (2012) 1.50
A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood (2008) 1.49
From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission. Brain Res Rev (2007) 1.42
Adducin forms a bridge between the erythrocyte membrane and its cytoskeleton and regulates membrane cohesion. Blood (2009) 1.42
Automated flow cytometric analysis of blood cells in cerebrospinal fluid: analytic performance. Am J Clin Pathol (2004) 1.41
A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis. J Biol Chem (2008) 1.41
Transport of PIP3 by GAKIN, a kinesin-3 family protein, regulates neuronal cell polarity. J Cell Biol (2006) 1.40
ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood (2002) 1.37
Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. Blood (2002) 1.37
Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand. Mol Pharm (2009) 1.36
Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery. Mol Pharmacol (2004) 1.35
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. Int J Cancer (2008) 1.34
Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted (99m)Tc-radioimaging agents. Mol Pharm (2009) 1.31
Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA (2005) 1.30
Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum (2002) 1.30
Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3. Blood (2011) 1.29
Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Lett (2004) 1.28
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer (2010) 1.27
A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3. J Biol Chem (2003) 1.26
Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. J Biomed Opt (2003) 1.26
Erythrocyte detergent-resistant membrane proteins: their characterization and selective uptake during malarial infection. Blood (2003) 1.26
T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer. J Clin Oncol (2006) 1.24
SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood (2004) 1.23
Mapping of glycolytic enzyme-binding sites on human erythrocyte band 3. Biochem J (2006) 1.23
Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low- and high-grade glioma surgery. J Biomed Opt (2011) 1.23
Modulation of red cell glycolysis: interactions between vertebrate hemoglobins and cytoplasmic domains of band 3 red cell membrane proteins. Am J Physiol Regul Integr Comp Physiol (2004) 1.23
Identification of a critical ankyrin-binding loop on the cytoplasmic domain of erythrocyte membrane band 3 by crystal structure analysis and site-directed mutagenesis. J Biol Chem (2002) 1.23
Characterization of glycolytic enzyme interactions with murine erythrocyte membranes in wild-type and membrane protein knockout mice. Blood (2008) 1.23
An osmotically induced cytosolic Ca2+ transient activates calcineurin signaling to mediate ion homeostasis and salt tolerance of Saccharomyces cerevisiae. J Biol Chem (2002) 1.22
Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood (2002) 1.20
Combined deletion of mouse dematin-headpiece and beta-adducin exerts a novel effect on the spectrin-actin junctions leading to erythrocyte fragility and hemolytic anemia. J Biol Chem (2006) 1.19
Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1. J Biol Chem (2008) 1.18
Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents. Arch Pathol Lab Med (2012) 1.17
Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts. J Biol Chem (2008) 1.16
Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance. Hum Pathol (2008) 1.14
Dlg1, Sec8, and Mtmr2 regulate membrane homeostasis in Schwann cell myelination. J Neurosci (2009) 1.13
Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: implications for O2 regulation of erythrocyte properties. Blood (2007) 1.13
Modulation of Gardos channel activity by cytokines in sickle erythrocytes. Blood (2002) 1.13
Synthesis and activity of a folate peptide camptothecin prodrug. Bioorg Med Chem Lett (2006) 1.12
Imaging of the diffusion of single band 3 molecules on normal and mutant erythrocytes. Blood (2009) 1.12
Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis. Blood (2012) 1.11
Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA (2003) 1.11
The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer. Cell Oncol (Dordr) (2011) 1.10
Calpain is required for normal osteoclast function and is down-regulated by calcitonin. J Biol Chem (2006) 1.10
The effector domain of human Dlg tumor suppressor acts as a switch that relieves autoinhibition of kinesin-3 motor GAKIN/KIF13B. Biochemistry (2007) 1.10
Role of band 3 in regulating metabolic flux of red blood cells. Proc Natl Acad Sci U S A (2009) 1.10
9-(Arenethenyl)purines as dual Src/Abl kinase inhibitors targeting the inactive conformation: design, synthesis, and biological evaluation. J Med Chem (2009) 1.10
Hypoxia activates a Ca2+-permeable cation conductance sensitive to carbon monoxide and to GsMTx-4 in human and mouse sickle erythrocytes. PLoS One (2010) 1.09
Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts. Nature (2012) 1.09
Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol (2004) 1.08
Functional expression of beta-chemokine receptors in osteoblasts: role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts. Endocrinology (2005) 1.08
Centaurin-alpha1 interacts directly with kinesin motor protein KIF13B. J Cell Sci (2005) 1.07
D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J Neurosci (2003) 1.06
Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma. Nat Commun (2013) 1.06
Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets. Mol Cell Biol (2007) 1.06
Peroxiredoxin-2 expression is increased in beta-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stress. Free Radic Biol Med (2010) 1.06
LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy. J Cell Sci (2012) 1.05
Disruption of erythroid K-Cl cotransporters alters erythrocyte volume and partially rescues erythrocyte dehydration in SAD mice. J Clin Invest (2007) 1.05
Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res Ther (2006) 1.05
In vitro genetic analysis of an erythrocyte determinant of malaria infection. J Infect Dis (2010) 1.04
Cholesterol level regulates endosome motility via Rab proteins. Biophys J (2007) 1.04
Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis. Clin Chem Lab Med (2010) 1.04
Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells. Int J Cancer (2005) 1.04
Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate. Arthritis Res Ther (2011) 1.03
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. Nucl Med Biol (2003) 1.03